Literature DB >> 18078824

Role of intracellular cAMP in differentiation-coupled induction of resistance against oxidative damage in Leishmania donovani.

Arijit Bhattacharya1, Arunima Biswas, Pijush K Das.   

Abstract

Even though the human parasite Leishmania donovani encounters tremendous oxidative burst during macrophage invasion, a set of parasites survives and proliferates intracellularly, leading to transformation from promastigote to amastigote form and disease manifestation. The striking shifts in temperature (from 22 degrees C in the insect gut to 37 degrees C in the mammalian host) and pH (7.2 in the insect gut to 5.5 in the parasitophorous vacuole of macrophages) are the key environmental triggers for differentiation as these cause an arrest in the G1 stage of the cell cycle and initiate transformation. Using an established in vitro culture and differentiation system our study demonstrates that the differentiation-triggering environment induces resistance to oxidative damage and consequently enhances infectivity. Differentiation conditions caused a three- to fourfold elevation in cAMP level as well as cAMP-dependent protein kinase activity. Similar to stress exposure, positive modulation of intracellular cAMP resulted in blockage of cell cycle progression and induction of resistance against oxidative damage. Resistance against pro-oxidants from either stress or cAMP may be associated with upregulation of the expression of three major antioxidant genes, peroxidoxin 1, trypanothione reductase, and superoxide dismutase A. Positive modulation of the intracellular cAMP response enables cells to resist the cytotoxic effects of pro-oxidants. In contrast, downregulation of intracellular cAMP by overexpression of cAMP phosphodiesterase A resulted in a decrease in resistance against oxidative damage and reduced infectivity toward activated macrophages. This study for the first time reveals the importance of cAMP response in the life cycle and infectivity of the Leishmania parasite.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078824     DOI: 10.1016/j.freeradbiomed.2007.10.059

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  Evolutionary analysis of globin domains from kinetoplastids.

Authors:  Akash Mitra; Kusumita Acharya; Arijit Bhattacharya
Journal:  Arch Microbiol       Date:  2022-07-16       Impact factor: 2.667

2.  Globin-coupled heme containing oxygen sensor soluble adenylate cyclase in Leishmania prevents cell death during hypoxia.

Authors:  Sumit Sen Santara; Jayasree Roy; Supratim Mukherjee; Moumita Bose; Rina Saha; Subrata Adak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

3.  Cyclic Nucleotide-Specific Phosphodiesterases as Potential Drug Targets for Anti-Leishmania Therapy.

Authors:  Victor Sebastián-Pérez; Sarah Hendrickx; Jane C Munday; Titilola Kalejaiye; Ana Martínez; Nuria E Campillo; Harry de Koning; Guy Caljon; Louis Maes; Carmen Gil
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

4.  Distinct roles in autophagy and importance in infectivity of the two ATG4 cysteine peptidases of Leishmania major.

Authors:  Roderick A M Williams; Jeremy C Mottram; Graham H Coombs
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

5.  Role of cAMP Signaling in the Survival and Infectivity of the Protozoan Parasite, Leishmania donovani.

Authors:  Arunima Biswas; Arijit Bhattacharya; Pijush K Das
Journal:  Mol Biol Int       Date:  2011-06-05

6.  Reactivation of flagellar motility in demembranated Leishmania reveals role of cAMP in flagellar wave reversal to ciliary waveform.

Authors:  Aakash Gautam Mukhopadhyay; Chinmoy Sankar Dey
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

Review 7.  Adenylate Cyclases of Trypanosoma brucei, Environmental Sensors and Controllers of Host Innate Immune Response.

Authors:  Didier Salmon
Journal:  Pathogens       Date:  2018-04-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.